Related Experiment Video
Updated: Jun 27, 2026

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
Targeting Skin Cancer with Natural Bioactive Compounds: From Molecular Mechanisms to Application Strategies
Yuan Gao1, Zesen Fang1, Yan Xu1
1School of Pharmacy, Engineering Research Center of Natural Antineoplastic Drugs, Ministry of Education, Harbin University of Commerce, Harbin 150076, China.
Abstract:
Skin cancer presents a significant global health burden with rising incidence. The side effects of current therapies and the emergence of drug resistance necessitate the exploration of alternative and complementary strategies. Natural products, with their long history of use in treating skin disorders, have emerged as a promising source of novel therapeutic agents. This review comprehensively elucidates the potential efficacy of natural bioactive compounds in both preventing and treating skin cancer. We summarize the molecular mechanisms through which key natural bioactive compounds exert their anti-skin cancer effects, including induction of apoptosis, inhibition of proliferation and metastasis, anti-inflammatory and antioxidant activities, DNA damage repair, and photoprotection. Furthermore, we discuss the biological barriers relevant to skin cancer therapy using natural bioactive compounds and link them to corresponding delivery strategies, while identifying key translational challenges. In conclusion, natural bioactive compounds offer a multi-targeted and synergistic approach against skin carcinogenesis, holding substantial promise as sources of adjuvant therapies and chemopreventive agents to improve patient outcomes.
Insights
Natural compounds show promise for preventing and treating skin cancer by targeting multiple pathways. These agents offer a synergistic approach to combat skin carcinogenesis and improve patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Dermatology
Background:
- Skin cancer incidence is rising globally, posing a significant health challenge.
- Current therapies face limitations due to side effects and drug resistance.
- Natural products offer a historical and promising avenue for novel skin cancer treatments.
Purpose of the Study:
- To review the efficacy of natural bioactive compounds in skin cancer prevention and treatment.
- To elucidate the molecular mechanisms of action for these compounds.
- To discuss delivery strategies and translational challenges for natural product-based therapies.
Main Methods:
- Comprehensive literature review of natural bioactive compounds and their anti-skin cancer effects.
- Summary of molecular mechanisms including apoptosis induction, proliferation inhibition, and anti-inflammatory/antioxidant activities.
- Analysis of biological barriers and delivery strategies for natural products in skin cancer therapy.
Main Results:
- Natural bioactive compounds demonstrate multi-targeted effects against skin cancer.
- Mechanisms include apoptosis induction, proliferation/metastasis inhibition, and DNA repair.
- Photoprotective, anti-inflammatory, and antioxidant properties contribute to efficacy.
Conclusions:
- Natural bioactive compounds present a promising, multi-targeted strategy against skin carcinogenesis.
- They hold potential as adjuvant therapies and chemopreventive agents.
- Addressing biological barriers and delivery is key for clinical translation.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Modified-Release Drug Delivery Systems: Site-Targeted
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)